Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Opioid Dependency: full-pipeline trial registry
1 of 3 indexed Opioid Dependency trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Opioid Dependency: 3 US clinical trials tracked, 1 recruiting.
Opioid Dependency is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Titan Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition opioid-dependency
OPEN 1 | RECR 33% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Opioid Dependency lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Opioid Dependency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Opioid Dependency is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Preoperative Opioid Tapering Before Spine Surgery
Thomas Jefferson University
NCT07221786
Re-Treatment Study of Probuphine in Opioid Addiction
Titan Pharmaceuticals
NCT01262261
Transdermal Electroacupuncture for Opioid Detoxification
Mclean Hospital
NCT00742170
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Opioid Dependency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Opioid Dependency trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Opioid Dependency page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Opioid Dependency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Titan Pharmaceuticals sponsors the most Opioid Dependency trials on record, review their full trial history before evaluating a specific study. See Titan Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Opioid Dependency condition card totals 3 registered trials; most-linked intervention Probuphine (buprenorphine implant); top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.